13F

Stock

Corcept Therapeutics Inc

CORT · held by 14 managers

Reported value

$114.2M

Holders

14

+1 new · −1 exited

Holders’ est. mark

$594.2K

Price effect on 7 books still in the name

Largest holder

$98.6M

MORGAN STANLEY

Holder count by quarter

Who holds it

Notable only
InvestorSharesValueEst. markChange
MORGAN STANLEY1.19M$98.6MHeld
BANK OF AMERICA CORP /DE/111.3K$9.25MHeld
OP Asset Management Ltd15.8K$1.31M$153.3KAdded$153.3K
Cresset Asset Management, LLC14K$1.16M$135.5KAdded$57.4K
BARCLAYS PLC13K$1.08M$126KCut−$3.28M
Allworth Financial LP9.1K$756KHeld
Sanctuary Advisors, LLC7.91K$657.6K$76.8KCut−$24.8K
Savant Capital, LLC6.45K$535.6K$58.5KAdded$93.4K
Swiss Life Asset Management Ltd4.52K$375.6KNew
DGS Capital Management, LLC4.22K$350.5K$40.9KCut−$15.4K
Essential Partners LLC591$49.1K$3.1KAdded$25.7K
IFP Advisors, Inc342$28.4KHeld
Kilter Group LLC23$1.91KHeld
KBC Group NV5.21K$433Held

Who left

Positions as of Q3 2025. 13F filings arrive up to 45 days after quarter-end and omit shorts. Values are quarter-end marks, as filed. Estimated mark is the price effect on shares still held — not realized P&L or investment advice.